Remove Layoffs Remove Pricing Remove Software Review Remove Technical Review
article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.

article thumbnail

How will you ride the next wave?

Berkonomics

We use gestures or our voice to control our engagement with our technology. It won’t be long before another round of layoffs comes, and these new tools will create new jobs to fill the gap. We use QR codes to simplify the process. None of this could be mined successfully in the past generation of technology.

Mobile 156